Cannabis is not immune to addiction. Despite there is a debated topic in both journalism and social field. But it is not like that for the science.
The fact that cannabis has a strong medical and therapeutic potential is not new. Indeed, the question we should ask is not about if medical cannabis works: the key question is how to get the maximum therapeutic benefit from cannabis and what combination of cannabinoids is the most efficient.
The Scottish Medicines Consortium has announced that Epidyolex will be the first cannabis-based medicine to be approved for use on the NHS. The CBD-based drug is used to treat rare forms of treatment-resistant epilepsy in children.
The NHS is exploring the possibility of manufacturing medical cannabis products for clinical trials of children who suffer from severe epilepsy. Compounds known as cannabinoids which are found in the cannabis plant have been found to have some anti-seizure potential in certain forms of the condition.
Two cannabis-based medicines, used to treat epilepsy and multiple sclerosis, have been approved for use by the NHS in England.